NorthRock Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.47M | Buy |
28,489
+16,186
| +132% | +$1.55M | 0.04% | 185 |
|
|
2025
Q4 | $1.18M | Sell |
12,303
-5,163
| -30% | -$502K | 0.02% | 252 |
|
|
2025
Q3 | $1.66M | Buy |
17,466
+4,049
| +30% | +$372K | 0.03% | 244 |
|
|
2025
Q2 | $1.18M | Buy |
13,417
+1,883
| +16% | +$160K | 0.03% | 212 |
|
|
2025
Q1 | $1.04M | Sell |
11,534
-396
| -3% | -$35.4K | 0.03% | 199 |
|
|
2024
Q4 | $959K | Buy |
11,930
+139
| +1% | +$12K | 0.03% | 213 |
|
|
2024
Q3 | $1.07M | Sell |
11,791
-362
| -3% | -$30.5K | 0.04% | 202 |
|
|
2024
Q2 | $963K | Sell |
12,153
-266
| -2% | -$21.8K | 0.04% | 201 |
|
|
2024
Q1 | $1.09M | Sell |
12,419
-27
| -0.2% | -$2.3K | 0.04% | 189 |
|
|
2023
Q4 | $1.03M | Buy |
12,446
+6,761
| +119% | +$515K | 0.04% | 191 |
|
|
2023
Q3 | $445K | Buy |
5,685
+79
| +1% | +$6.61K | 0.05% | 171 |
|
|
2023
Q2 | $494K | Sell |
5,606
-658
| -11% | -$56.6K | 0.05% | 140 |
|
|
2023
Q1 | $505K | Buy |
6,264
+3,183
| +103% | +$259K | 0.05% | 149 |
|
|
2022
Q4 | $239K | Sell |
3,081
-3,227
| -51% | -$262K | 0.03% | 301 |
|
|
2022
Q3 | $509K | Buy |
6,308
+720
| +13% | +$64.7K | 0.06% | 140 |
|
|
2022
Q2 | $502K | Sell |
5,588
-2,996
| -35% | -$304K | 0.05% | 151 |
|
|
2022
Q1 | $952K | Buy |
8,584
+655
| +8% | +$69.2K | 0.09% | 108 |
|
|
2021
Q4 | $820K | Sell |
7,929
-1,090
| -12% | -$126K | 0.06% | 118 |
|
|
2021
Q3 | $1.19M | Buy |
9,019
+3,977
| +79% | +$515K | 0.1% | 80 |
|
|
2021
Q2 | $626K | Buy |
5,042
+2,376
| +89% | +$298K | 0.05% | 119 |
|
|
2021
Q1 | $315K | Buy |
2,666
+178
| +7% | +$20.9K | 0.03% | 171 |
|
|
2020
Q4 | $291K | Buy |
2,488
+188
| +8% | +$20.7K | 0.03% | 178 |
|
|
2020
Q3 | $239K | Sell |
2,300
-241
| -9% | -$24.2K | 0.03% | 188 |
|
|
2020
Q2 | $233K | Buy |
2,541
+150
| +6% | +$14.4K | 0.03% | 180 |
|
|
2020
Q1 | $216K | Sell |
2,391
-1,276
| -35% | -$136K | 0.03% | 177 |
|
|
2019
Q4 | $416K | Sell |
3,667
-1,317
| -26% | -$145K | 0.04% | 170 |
|
|
2019
Q3 | $544K | Buy |
+4,984
| New | +$520K | 0.07% | 124 |
|
|
2019
Q2 | – | Sell |
-2,644
| Closed | -$243K | – | 88 |
|
|
2019
Q1 | $243K | Sell |
2,644
-690
| -21% | -$61.8K | 0.06% | 73 |
|
|
2018
Q4 | $275K | Buy |
3,334
+758
| +29% | +$70.8K | 0.08% | 69 |
|
|
2018
Q3 | $254K | Sell |
2,576
-1,507
| -37% | -$139K | 0.07% | 53 |
|
|
2018
Q2 | $352K | Buy |
+4,083
| New | +$341K | 0.12% | 35 |
|
|
2017
Q1 | – | Sell |
-3,512
| Closed | -$249K | – | 51 |
|
|
2016
Q4 | $249K | Buy |
3,512
+241
| +7% | +$18.9K | 0.09% | 45 |
|
|
2016
Q3 | $285K | Sell |
3,271
-135
| -4% | -$11.8K | 0.12% | 32 |
|
|
2016
Q2 | $294K | Sell |
3,406
-737
| -18% | -$59.6K | 0.13% | 33 |
|
|
2016
Q1 | $313K | Buy |
4,143
+594
| +17% | +$44.7K | 0.16% | 25 |
|
|
2015
Q4 | $274K | Sell |
3,549
-106
| -3% | -$7.98K | 0.16% | 26 |
|
|
2015
Q3 | $245K | Sell |
3,655
-3,425
| -48% | -$252K | 0.15% | 31 |
|
|
2015
Q2 | $524K | Buy |
7,080
+331
| +5% | +$25.3K | 0.24% | 25 |
|
|
2015
Q1 | $527K | Buy |
+6,749
| New | +$512K | 0.31% | 22 |
|
Other funds holding MDT
VCM
VPM
NorthRock Partners's MDT Position: Q1 2026 in Review
NorthRock Partners increased its Medtronic (MDT) stake by 132% in Q1 2026, buying an estimated $1.55M and bringing the position to 28,489 shares worth $2.47M. The position accounts for 0.04% of the portfolio, ranked #185.
NorthRock Partners first reported a position in MDT in Q1 2015 and has held it in 39 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- NorthRock Partners held 28,489 shares of Medtronic worth $2.47M as of Q1 2026.
- NorthRock Partners bought 16,186 Medtronic shares in Q1 2026, an estimated $1.55M.
- Medtronic made up 0.04% of NorthRock Partners's portfolio in Q1 2026, its #185 holding.
- NorthRock Partners first reported a position in Medtronic in Q1 2015 and has held it in 39 quarters since.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.